Jefferies Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.02M | Hold |
25,000
| – | – | 0.02% | 609 |
|
|
2022
Q2 | $2.24M | Buy |
+25,000
| New | +$2.53M | 0.02% | 584 |
|
|
2021
Q4 | – | Sell |
-25,000
| Closed | -$3.13M | – | 1863 |
|
|
2021
Q3 | $3.13M | Hold |
25,000
| – | – | 0.02% | 585 |
|
|
2021
Q2 | $3.1M | Buy |
+25,000
| New | +$3.14M | 0.02% | 601 |
|
|
2021
Q1 | – | Sell |
-13,800
| Closed | -$1.62M | – | 1844 |
|
|
2020
Q4 | $1.62M | Hold |
13,800
| – | – | 0.01% | 783 |
|
|
2020
Q3 | $1.43M | Sell |
13,800
-18,300
| -57% | -$1.84M | 0.02% | 692 |
|
|
2020
Q2 | $2.94K | Buy |
32,100
+11,000
| +52% | +$1.05M | 0.03% | 420 |
|
|
2020
Q1 | $1.9M | Buy |
21,100
+4,400
| +26% | +$468K | 0.02% | 712 |
|
|
2019
Q4 | $1.9M | Sell |
16,700
-27,300
| -62% | -$3M | 0.01% | 1086 |
|
|
2019
Q3 | $4.78M | Sell |
44,000
-164,700
| -79% | -$17.2M | 0.04% | 544 |
|
|
2019
Q2 | $20.3M | Buy |
208,700
+187,600
| +889% | +$17.1M | 0.15% | 99 |
|
|
2019
Q1 | $1.92M | Sell |
21,100
-42,100
| -67% | -$3.77M | 0.02% | 937 |
|
|
2018
Q4 | $5.75M | Sell |
63,200
-43,800
| -41% | -$4.09M | 0.05% | 364 |
|
|
2018
Q3 | $10.5M | Sell |
107,000
-10,600
| -9% | -$980K | 0.07% | 256 |
|
|
2018
Q2 | $10.1M | Buy |
117,600
+74,900
| +175% | +$6.26M | 0.06% | 264 |
|
|
2018
Q1 | $3.42M | Buy |
42,700
+11,700
| +38% | +$965K | 0.02% | 622 |
|
|
2017
Q4 | $2.5M | Sell |
31,000
-97,800
| -76% | -$7.83M | 0.01% | 877 |
|
|
2017
Q3 | $10M | Buy |
128,800
+97,300
| +309% | +$8.08M | 0.07% | 272 |
|
|
2017
Q2 | $2.8M | Sell |
31,500
-54,400
| -63% | -$4.59M | 0.02% | 794 |
|
|
2017
Q1 | $6.92M | Sell |
85,900
-77,000
| -47% | -$6.01M | 0.05% | 378 |
|
|
2016
Q4 | $11.6M | Buy |
162,900
+132,100
| +429% | +$10.4M | 0.06% | 293 |
|
|
2016
Q3 | $2.66M | Sell |
30,800
-57,100
| -65% | -$4.98M | 0.01% | 797 |
|
|
2016
Q2 | $7.63M | Sell |
87,900
-7,600
| -8% | -$615K | 0.03% | 359 |
|
|
2016
Q1 | $7.16M | Sell |
95,500
-35,600
| -27% | -$2.68M | 0.04% | 357 |
|
|
2015
Q4 | $10.1M | Buy |
131,100
+25,900
| +25% | +$1.95M | 0.06% | 261 |
|
|
2015
Q3 | $7.04M | Sell |
105,200
-217,300
| -67% | -$16M | 0.04% | 359 |
|
|
2015
Q2 | $23.9M | Buy |
322,500
+238,100
| +282% | +$18.2M | 0.12% | 139 |
|
|
2015
Q1 | $6.58M | Buy |
+84,400
| New | +$6.4M | 0.04% | 337 |
|
|
2014
Q4 | – | Sell |
-130,000
| Closed | -$8.05M | – | 2195 |
|
|
2014
Q3 | $8.05M | Buy |
+130,000
| New | +$8.27M | 0.06% | 290 |
|
|
2013
Q4 | – | Sell |
-64,700
| Closed | -$3.44M | – | 2104 |
|
|
2013
Q3 | $3.44M | Buy |
+64,700
| New | +$3.48M | 0.03% | 425 |
|
Other funds holding MDT
Jefferies Group's MDT Position: Q3 2022 in Review
Jefferies Group increased its Medtronic (MDT) stake by 2,375% in Q3 2022, buying an estimated $719K and bringing the position to 8,341 shares worth $674K. The position accounts for 0.01% of the portfolio, ranked #933.
Jefferies Group first reported a position in MDT in Q2 2013 and has held it in 35 quarters since. The position peaked at $23.9M in Q4 2016. 1,930 funds tracked by Wall St. Rank hold MDT as of Q3 2022.
- Jefferies Group held 8,341 shares of Medtronic worth $674K as of Q3 2022.
- Jefferies Group bought 8,004 Medtronic shares in Q3 2022, an estimated $719K.
- Medtronic made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #933 holding.
- Jefferies Group first reported a position in Medtronic in Q2 2013 and has held it in 35 quarters since.
- Jefferies Group's Medtronic position peaked at $23.9M in Q4 2016.
- 1,930 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.